Navigation Links
Gut microbiome analysis improved noninvasive colorectal cancer screening
Date:8/6/2014

PHILADELPHIA Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to data published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

"A person's gut microbiome is the collection of all the bacteria in their gut," said Patrick D. Schloss, PhD, associate professor in the Department of Microbiology and Immunology at the University of Michigan in Ann Arbor. "The number of bacteria in the gut is huge; it outnumbers the number of cells in our bodies 10 to one, and the diversity of the bacteria present is critical to our health. By sequencing the V4 region of the 16S rRNA gene we were able to identify the bacteria present in each individual's gut microbiome.

"We found that the composition of the gut microbiome allowed us to identify who in our study had precancerous adenomatous polyps and who had invasive colorectal cancer," continued Schloss. "If our results are confirmed in larger groups of people, adding gut microbiome analysis to other fecal tests may provide an improved, noninvasive way to screen for colorectal cancer."

By analyzing stool samples from 90 individuals30 healthy individuals, 30 patients with precancerous adenomatous polyps, and 30 patients with invasive colorectal cancerSchloss and his colleagues established that the composition of the gut microbiome was different for individuals in the three groups.

Using this information, they identified gut microbiome signatures for each group. Adding analysis of these signatures to assessment of age and race, which are clinical risk factors for precancerous adenomatous polyps, improved prediction of the presence of precancerous adenomatous polyps 4.5-fold. Adding analysis of the gut microbiome signatures to assessment of age, race, and body mass index (BMI), which are clinical risk factors of invasive colorectal cancer, improved prediction of the presence of invasive colorectal cancer 5.4-fold.

In addition, analysis of the gut microbiome signatures was better than fecal occult blood testing at distinguishing individuals with precancerous adenomatous polyps from those with invasive colorectal cancer (AUC=0.617 and AUC=0.952, respectively). Assessing BMI, fecal occult blood test results, and gut microbiome signatures together further improved the ability to distinguish between the two conditions (AUC=0.969).

"Our data show that gut microbiome analysis has the potential to be a new tool to noninvasively screen for colorectal cancer," said Schloss. "We don't think that this would ever replace other colorectal cancer screening approaches, rather we see it as complementary.

"The study involved not just microbiologists but also researchers skilled in statistics, genomics, and epidemiology," continued Schloss. "Its success shows just how important interdisciplinary science is."


'/>"/>
Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Blood sugar improves with first gastrointestinal microbiome modulator, NM504
2. Gastroenterology highlights new microbiome research
3. The lung microbiome: A new frontier in pulmonary medicine
4. Decreased diversity of bacteria microbiome in the gut is associated with risk of colorectal cancer
5. Genetic makeup and diet interact with the microbiome to impact health
6. After the human genome project: The human microbiome project
7. Kittens: Their microbiomes are what they eat
8. US Online Retail Dynamics Market: Consumer Attitudes Analysis & 2018 Forecasts Now Available at MarketReportsOnline.com
9. Speedier diagnosis of diseases such as cancer likely thanks to new DNA analysis technique
10. Diagnostic Medical Imaging Equipment Industry Global and Chinese Analysis for 2009-2019 in New Research Report at RnRMarketResearch.com
11. United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... BROOK, Ill. (PRWEB) , ... December 06, 2016 ... ... disruptions in their brain networks that can be seen on a type of ... disease (PD) is a progressive disorder of the central nervous system characterized by ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum disease are ... serious health problems, such as cardiovascular illness, according to research cited in a ... Periodontics & Dental Implant Center notes that the correlation between periodontal disease and ...
(Date:12/6/2016)... ... ... According to a November 1 article published on Bustle, there ... drinking enough water, which can cause bad breath (known medically as halitosis). Dr. Farzad ... not only helps reduce the possibility of bad breath, but it can provide individuals ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... named Ajdin Camaga as a vice president of sales. , “Ajdin understands that ... “He works hard to understand what each client needs, and is persistent in ...
(Date:12/6/2016)... ... December 06, 2016 , ... Mount Sinai Health System today ... of Neurosurgery, where clinicians can confer and order 3D models for their cases. ... basis with quick turnaround times. This resource will be the first of its ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  Nearly 30 million people in ... the epidemic of diabetes. 1 However, nearly 40% ... glucose levels (hyperglycemia) and significant glucose variability. 2 These ... including cardiovascular events. If left untreated, hyperglycemia can lead ... disease or blindness. 3 As part ...
(Date:12/6/2016)... , Dec. 6, 2016 With opioids commonly used for ... the prescription drug market that has led to nationwide fatalities. ... to eight times stronger than heroin or morphine, resulting in likelihood ... , ... , vice president, clinical operations, Behavioral Health for HMC HealthWorks, explained ...
(Date:12/6/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... for patients with genomically defined diseases, today announced that ... million in shares of its common stock. In addition, ... option to purchase up to an additional of $18,750,000 ... with the public offering. All shares of common stock ...
Breaking Medicine Technology: